PHARMACEUTICAL TESTING

Similar documents
EXTRACTABLE & LEACHABLES SERVICES

SGS Delivering Excellence in Compliant Extractables and Leachables Testing

Image Area YOUR PRESCRIPTION FOR USP 232/233 COMPLIANCE. USP 232 / 233 Readiness Solutions and Services Overview

Elemental impurities impact on APIs

Analytical Methods Development and Validation

Excipients Facing Increased Scrutiny How to Use Secondary Reference Standards to Help Maintain Regulatory Compliance

Impact of New ICH Q3D and USP <232> Guidelines for Elemental Impurities Analyses

Impurities from degradation of Drug Substances

Purification, Purity Analysis, and Impurity Analysis Solutions. for Pharmaceutical Research and Development

Laboratory Services Alcami s comprehensive development and testing services are well established and ready to assist your pharmaceutical product

Quality Issues for Clinical Trial Materials: The Chemistry, Manufacturing and Controls (CMC) Review

Developing a Best Practice Guide for Leachables Risk Assessment, Study Design, and Analytical Methods

PPD LABORATORIES COMPREHENSIVE SERVICES

Validation/Verification of Test Methods An FDA Perspective. Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness

Extractables and leachables: An Introduction

Agilent Resources for Workflow Compliance MEASURING ELEMENTAL IMPURITIES IN PHARMACEUTICAL MATERIALS

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

Analytical Services. Analytical solutions for chemical, pharmaceutical, nutraceutical and cosmetic companies

Intertek Melbourn Company Presentation. MIBio 2016

Control Strategy. Implementation of ICH Q8, Q9, Q10

Elemental Impurities Regulations View from a CRO

LAB EXPERTS AT YOUR SIDE Over twenty years of experience

Validation Needs for Sterilization by Aseptic Filtration

Your bridge to. better medicines

Regulatory expectations on impurities in drug substances - Pavia, October 2, Luisa Torchio Euticals SpA

Dealing with Extractables & Leachables from a Regulatory Perspective - Design of Extractables & Leachables Studies - Safety Assessment of Leachables

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Leachable and Extractable Testing

API Stability Protocols and. Chris Byrne Tasmanian Alkaloids

AMRI Acquires Whitehouse Laboratories Investment Community Presentation. December 15, 2015

Elementverunreinigungen in Pharmaprodukten Neue Limits und Verfahren zur Bestimmung nach USP

REGULATORY ASSURANCE R&D SUPPORT

Elemental Impurities Testing at a Pharmaceutical Company

Derivation and Justification of Safety Thresholds

DEVELOPING AN IN VITRO RELEASE TESTING (IVRT) METHOD FOR THE VALIDATION OF SEMI-SOLID TOPICAL FORMULATIONS

How do you know the drug you are using is safe and effective?


The European Pharmacopoeia

Technical requirements to Good Manufacturing Practice in metered dose inhalers production and development (2. part) Extractable - Leachable

Perspectives on Method Validation: Importance of Adequate Method Validation

FDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS

Analysis of Protein Biopharmaceuticals

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization

How to implement ICH Q3D of elemental impurities in 5 steps

LEGAL REQUIREMENTS FOR STABILITY

Quality assurance at a high level

Overview of Impurities

3M Drug Delivery Systems. April 26, 2011

Essentials in Stability Analysis and Expiry Determination

Primary / secondary standards in pharmaceutical QC. Dr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013

Documentation requirements for an initial consultation

API Testing Requirements to Support the EI Risk Assessment. Elisabeth Corbett Associate Director, GRS-CMC, Bristol-Myers Squibb November 9, 2016

ADVANCED TESTING LABORATORY

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

BRIEFING. . Over time, 466 may be used less frequently and may be withdrawn.

WHO DRAFT PHARMACEUTICAL DEVELOPMENT FOR MULTISOURCE (GENERIC) PHARMACEUTICAL PRODUCTS

COMMERCIAL PRODUCT STABILITY

R&D of Biological Products. Rochapon Wacharotayankun, Ph.D., R.Ph.

Agilent solutions for contract research and manufacturing organizations

Stability of Biological Products

CGMP Requirements for Investigational Products

Consultation by a notified body on an ancillary medicinal substance integrated in a medical device

Inspection. Implementation of ICH Q8, Q9, Q10

MDI Manufacturing Services

Evaluating single-use systems

Question-based Review (QbR)

1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country

A Generic Industry Perspective on Establishing Impurity Limits And a Corresponding Control Strategy

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

Impact factor: 3.958/ICV: 4.10 ISSN:

Regulatory Considerations on. Office of Biotechnology Products

Review article Rapports De Pharmacie 2015;1(2):46-53 ISSN:

ICH Q3D Guideline Impact on the Users: Perspective of a Finished Product Manufacturer John Glennon

Process Drift: When Do We Detect it? Richard L. Friedman Director, DMPQ CDER/Office of Compliance PQRI Process Drift Workshop December 1, 2010

Development of Elemental Impurity risk assessments for existing prescription products

Analytical and formulation attributes

Journal of Atoms and Molecules

Elemental Impurities: An Industry Perspective

GUIDELINE FOR THE STABILITY TESTING

PURITAN PRODUCTS QUALITY OVERVIEW. Quality Management System Self-Audit. September 15, 2015

EXCELLENCE ANALYTICAL CHEMISTRY

4 Key Considerations When Engaging A New GMP Contract Service Provider

á1225ñ VALIDATION OF COMPENDIAL PROCEDURES

Approval Review of Generic Drugs. Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D.

3M Purification Inc. Technical and Scientific Services Global Support for the Life Science Industry. Global Expertise delivered locally

Scientific and Regulatory Perspectives on Measuring Protein Aggregation of Biotechnology Products

Switzerland EXPERTS TAKING CARE

EXCELLENCE ANALYTICAL CHEMISTRY

Comparing an instrumental technique based on its

Quality Control in the Synthesis of Atorvastatin Calcium Secondary Reference Standard Kits Help Generic Manufacturers Minimize Impurities

Colorants in Medical Devices:

2017 AAM CMC Workshop

Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A

STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS

MASTER FILE PROCEDURES

Key-points of Post approval variation in Korea

Regulatory Assessment

11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS. Siriphorn Laomanacharoen 21 December 2012

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A

Transcription:

WHITEHOUSE, NJ PHARMACEUTICAL TESTING Pharmaceutical Expertise for GMP & CMC Testing

Our Pharmaceutical Expertise With more than 20 years of experience in a variety of industries, our Whitehouse, New Jersey facility offers expertise in the development of drug products, pharmaceutical devices, formulations, and delivery systems to clients around the globe. With comprehensive solutions for pharmaceutical stability, discovery support, trace analysis, bioanalytical testing, regulatory compliance, and more, we are fully equipped to meet all of your needs for pharmaceutical testing. As a contract consulting analytical laboratory, we can help you address any challenges you may face in bringing your pharmaceutical products to market, ranging from the simplest solutions to the most complex analysis. Partnering with our Whitehouse facility brings the assurance, confidence, and peace of mind that comes with collaborating with a current good manufacturing practice (cgmp) compliant facility, ensuring that testing will be carried out to the most up-to-date and highest quality standards, preserving the integrity of your products.

Analytical Research & Development Discovery Support Services Bringing any pharmaceutical product to market requires an extensive amount of research and development to ensure the methods employed will serve the purpose of a particular product. Our discovery support services provide assurance that proper methods are developed and proper analyses and validations are conducted. cgmp Method Development, Validation and Remediation Method development works to establish the techniques that will be employed at each stage of the process in order to meet your objectives. Validation ensures that the methods are appropriate for a given product. Once methods have been developed and validated, the process then moves into the remediation phase, where these methods are continually evaluated and managed throughout the method s lifecycle to ensure it will continue to serve its purpose. We provide you with reliable, accurate, and efficient analytical methods necessary to establish the data needed to develop your products. Our technology includes chromatography, mass spectrometry, elemental analysis, and spectroscopy. Through our cgmp method development, validation, and remediation services, we ensure that the methods established meet regulatory requirements through our adherence to International Conference on Harmonisation (ICH) guidelines. We possess extensive expertise across a wide variety of formulations and molecules, including: Small molecules Biologics Nanoparticles Solids Patches Gels Ointments Liquids Inhaled products Cleaning Validations Ensuring the purity of drug products is crucial for reaching the market with speed and efficiency. Cleaning validations play a major role in ensuring drug products are free of contamination and suitable for manufacturing. Our cleaning validation techniques provide solutions for all manners of residues, from the simple to the complex. Through these methods, we are able to identify potential contaminants in formulations such as API residues and degradation species, as well as residues from detergents or solvents. This provides assurance that your products are free of any contaminants that would pose a danger to users and hinder the product s ability to enter the market. PHARMACEUTICAL SERVICES Cleaning validation capabilities: High pressure liquid chromatography-mass spectrometry (HPLC-MS) Ion chromatography (IC) Inductively coupled plasma spectroscopy with mass spectrometry (ICP-MS) Optical emission spectroscopy (ICP-OES) detection Pharmaceutical Analysis Conducting a pharmaceutical analysis helps provide a greater understanding of your substances, products, and processes. As a result, it can improve outcomes through all phases of the process from product development and submission to the FDA, manufacturing to post-marketing. Our pharmaceutical analysis services offer the capability to address concerns about drug safety, assuring that your products comply with regulatory requirements. Pharmaceutical Analysis Services: Research and development analytical support CMC analytical support Formulation development Clinical manufacturing Post-approval analytical support Manufacturing analytical support 3

PHARMACEUTICAL TESTING Extractables and Leachables The study of extractables and leachables (E&L) is a complex and involved process, which requires an in-depth analysis of drug products and devices. E&L studies are necessary to ensure packaging and/or container closure systems do not have the potential to release harmful compounds that could negatively impact drug products and pose a danger to consumers. Through controlled extractable studies (CES), we can quickly and accurately identify any such impurities that could potentially contaminate your products. All of our E&L studies are carried out in accordance with cgmp, PQRI recommendations, USP requirements, and FDA guidelines. We also provide complete identification of leachables and leachability and/or migration studies on polymeric medical devices or packaging. Our extensive array of extractables and leachables studies includes: Identification of extractables using GC/MS, GC/MS/MS, and LC MS/MS, according to USP <1663> Complex polymer formulation component identification Fast and accurate identification of extractables including transformation and degradation products Validation of leachables methods for use in stability and storage programs Custom studies for all types of container closure systems and primary packaging materials Modifying specific controlled extractables methods for routine E&L testing Screening or quantitative studies for additives and stabilizer ingredients and their degradation products Developing and validating methods for controlled extractables from pharmaceutical containers, closure and devices 4

PHARMACEUTICAL SERVICES Trace Analysis Any impurities in drug formulations and products, no matter how small, must be identified to ensure they are at levels that will not cause harm to consumers. Trace analysis identifies impurities present at trace levels (e.g., parts per million (ppm) levels) within a drug formulation, providing valuable data to make informed decisions about your products. Elemental Analysis and Trace Metals Given the toxicity of trace metals and the overall complexity of pharmaceutical products, it is critical to conduct elemental analysis and trace metals testing. Employing these measures brings an added element of quality control to the development process. Our techniques span a wide range of analytical technologies, including: Inductively coupled plasma mass spectrometry (ICP-MS) Inductively coupled plasma optical emission spectroscopy Ion chromatography (IC) Flame atomic absorption spectroscopy (FLAA) X-ray fluorescence (XRF) USP <232> and USP <233> Elemental Impurities Services If elemental impurities exist in pharmaceutical products, they must be quickly identified and corrected given their toxicity and the risk they would pose to a user. Elements such as lead, arsenic, cadmium, and mercury pose a known risk due to their toxicity, requiring an elemental analysis to quantify at what levels they are present. Through our strategic approach to demonstrating a product s compliance with both USP <232> (Elemental Impurities Limits) and <233> (Elemental Impurities Procedures), we offer routine analysis, semiquantitative screening, and method development and validation. Our comprehensive elemental impurities services include: Quality control testing Reference materials certification Stability testing GMP batch release testing Organic Volatile Impurity Analysis Although solvents may be necessary for the manufacture of APIs and drug substances the harm they could potentially cause requires that permissible daily exposure (PDE) be established to control the solvents present in products. We have extensive experience in residual solvent testing, specifically to USP <467>, providing assurance that any solvents found in your formulations are present at acceptable levels. Organic Volatile Impurity Analytical Capabilities Headspace gas chromatography Gas chromatography-mass spectrometry (GC-MS) Gravimetric techniques Method development to ICH Contact our industry experts today for your pharmaceutical testing needs +1 (800) 967 5352 5

PHARMACEUTICAL TESTING 6

PHARMACEUTICAL SERVICES Stability & Pharmaceutical Testing Stability testing provides the capability to evaluate the stability of your active pharmaceutical ingredients (APIs) and drug products under a number of different conditions including light, humidity, and temperature. Given the challenges such testing can present, it is important to collaborate with a partner that has expertise in developing stability methods and analyzing leachable substances. Storage and Stability Testing (Including Photostability): Storage and stability testing provide valuable information to pharmaceutical developers by assessing the stability of their products, particularly with regard to the risk for extractable and leachable components. Our worldwide network of ICH stability storage facilities provides the capability to assess the potential for extractable and leachable compounds in your products. Stability studies provide valuable data on recommended storage conditions, reset intervals, and shelf lives. Our vast storage and stability capabilities include: cgmp registration stability programs Design, storage, and management Tailored reporting (timepoint and final reports) Development and validation of stability indicating methods Real time stability testing Accelerated stability testing Formulation stability testing Extractables & leachables Forced degradation testing with degradation product identification & quantification Stability testing for APIs, clinical trial materials, and formulated products GC/M Comparator Studies Knowing how your products measure up against the competition provides a competitive advantage when entering the market. Our comparator studies allow you to see how your products compare in bioequivalence, efficacy, and safety. Our comprehensive comparator studies include: Method development and method validation Stability storage and testing Compendial and proprietary products Dissolution testing for Apparatus I, II, and IV Reference standard programs cgmp QC Testing Services and Laboratory Analysis To develop an effective and successful product, you must first ensure the raw materials used to produce it are of the highest quality. Given that these materials can vary between suppliers and batches, it is crucial to institute quality control measures to ensure the same level of quality across all of the raw materials in your products. To ensure you are utilizing the best materials throughout the development and manufacturing process, we provide testing of: Raw materials Excipients In-process samples Finished product batches Reference Standard Materials (RSM) Program In order to achieve accurate results for analytical methods, it s necessary to assess the purity and quality of reference standards. Our RSM qualification programs offer custom solutions in the areas of process impurity identification, assay, metabolite quantification, and degradation product quantification, among others. We provide custom study requirements that are tailored to your specific needs. Employing a three-tiered approach to qualification and requalification, we work with you to help avoid interruptions in your programs and address issues if a sample has shown to degrade. Our RSM programs include: Initial characterization Generation of a certificate of analysis Expiry dating through stability testing with ICH stability storage Repository and distribution Periodic requalification Complete characterization of reference standard materials (including sample limited materials) Safely speed your time to market with our comprehensive pharmaceutical testing. 7

Pharmaceutical-Testing_FS_C-BH Intertek Whitehouse P.O. Box 470 291 Route 22 East Salem Industrial Park, Bldg #5 Whitehouse, NJ 08888 +1 800 967 5352 (1-800-WORLDLAB) icenter@intertek.com www.intertek.com/pharmaceutical